Evidence map›Paper›PMID 34709943›Full record

ArticleJCO oncology practice2022

Infrastructure of Fertility Preservation Services for Pediatric Cancer Patients: A Report From the Children's Oncology Group.

Natasha N Frederick, James L Klosky, Lillian R Meacham, Gwendolyn P Quinn, Joanne Frankel Kelvin, Brooke Cherven, David R Freyer, Christopher C Dvorak, Julienne Brackett, Sameeya Ahmed-Winston and 3 more

Abstract read
In one paragraph

Article in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Fresh versus frozen micro-TESE sperm and outcomes.Asian journal of andrology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Natasha N FrederickCenter for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, CT.ORCID 0000-0001-6770-801X
James L KloskyAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA.ORCID 0000-0002-4081-0417
Lillian R MeachamAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA.
Gwendolyn P QuinnDivision of Medical Ethics, Departments of OB-GYN, Population Health, Grossman School of Medicine, New York University, New York, NY.ORCID 0000-0002-4208-9889
Joanne Frankel KelvinMemorial Sloan Kettering Cancer Center, New York, NY.
Brooke ChervenAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA.ORCID 0000-0002-5978-655X
David R FreyerCancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA.ORCID 0000-0001-5280-990X
Christopher C DvorakDivision of Pediatric Allergy, Immunology and Bone Marrow Transplant, University of California San Francisco, San Francisco, CA.ORCID 0000-0002-6146-3952
Julienne BrackettDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Houston, TX.
Sameeya Ahmed-WinstonCenter for Cancer and Blood Disorders, Children's National, Washington, DC.ORCID 0000-0002-4359-1520
Elyse BrysonAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA.
Eric J ChowClinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0001-7712-961X
Jennifer LevineWeill Cornell Medicine, Division of Pediatric Hematology and Oncology, New York, NY.ORCID 0000-0003-1417-0169

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Towards a preventive cancer vaccine for children with constitutional mismatch repair deficiencyUG1CA189955 · NCI · PUBLIC HEALTH INSTITUTE · PI BRAD H POLLOCK, Michael E. Roth · 2014 to 2026
$62.5M
NCI NIH HHS P30 CA008748NCI NIH HHS U10 CA180886NCI NIH HHS UG1 CA189955
6 · The paper itself

Abstract

purposeFertility preservation (FP) services are part of comprehensive care for those newly diagnosed with cancer. The capacity to offer these services to children and adolescents with cancer is unknown.

methodsA cross-sectional survey was sent to 220 Children's Oncology Group member institutions regarding institutional characteristics, structure and organization of FP services, and barriers to FP. Standard descriptive statistics were computed for all variables. The association between site-specific factors and selected outcomes was examined using multivariable logistic regression.

resultsOne hundred forty-four programs (65.5%) returned surveys. Fifty-three (36.8%) reported a designated FP individual or team. Sperm banking was offered at 135 (97.8%) institutions, and testicular tissue cryopreservation at 37 (27.0%). Oocyte and embryo cryopreservation were offered at 91 (67.9%) and 62 (46.6%) institutions, respectively; ovarian tissue cryopreservation was offered at 64 (47.8%) institutions. The presence of dedicated FP personnel was independently associated with the ability to offer oocyte or embryo cryopreservation (odds ratio [OR], 4.7; 95% CI, 1.7 to 13.5), ovarian tissue cryopreservation (OR, 2.7; 95% CI, 1.2 to 6.0), and testicular tissue cryopreservation (OR, 3.3; 95% CI, 1.4 to 97.8). Only 26 (18.1%) participating institutions offered all current nonexperimental FP interventions. Barriers included cost (70.9%), inadequate knowledge or training (60.7%), difficulty characterizing fertility risk (50.4%), inadequate staffing (45.5%), and logistics with reproductive specialties (38%-39%).

conclusionThis study provides the most comprehensive view of the current landscape of FP infrastructure for children and adolescents with cancer and demonstrates that existing infrastructure is inadequate to offer comprehensive services to patients. We discuss modifiable factors to improve patient access to FP.

Indexed as

Fertility PreservationNeoplasmsAdolescentCross-Sectional StudiesCryopreservationHumansOocytes

Identifiers

PMID34709943
PMCPMC8932529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.